(Q35628089)

9 August 2017

1 reference

title

Pruritus in chronic liver disease: mechanisms and treatment (English)

1 reference

9 August 2017

1 reference

chronic liver disease

0 references

author name string

Nora V Bergasa

series ordinal

1

1 reference

9 August 2017

language of work or name

1 reference

1 February 2004

1 reference

Current gastroenterology reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

10-16

1 reference

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0020-7

Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0020-7

Phenobarbital Effects in Cholestatic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0020-7

Effects of long-term rifampicin administration in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-004-0020-7

Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease

21 January 2018

1 reference

12 December 2020

Efficacy and safety of long-term phenobarbital therapy of familial cholestasis

1 reference

12 December 2020

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

1 reference

12 December 2020

Central mu-opioid receptors are down-regulated in a rat model of cholestasis

1 reference

12 December 2020

Uptake and efflux of the peptidic delta-opioid receptor agonist

1 reference

12 December 2020

The medullary dorsal horn: a target for the expression of opiate effects on the perceived intensity of noxious heat

1 reference

12 December 2020

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

1 reference

12 December 2020

Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.

1 reference

12 December 2020

Unilateral neurogenic pruritus following stroke

1 reference

12 December 2020

Gabapentin treatment for brachioradial pruritus

1 reference

12 December 2020

Cannabinoids as potential new analgesics

1 reference

12 December 2020

Itching after epidural and spinal opiates

1 reference

12 December 2020

Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities

1 reference

12 December 2020

The effects of naloxone associated with the intrathecal use of morphine in labor

1 reference

12 December 2020

Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome

1 reference

12 December 2020

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

12 December 2020

Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions

1 reference

12 December 2020

Pruritus as a symptom of hepatitis C.

1 reference

12 December 2020

Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching.

1 reference

12 December 2020

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group

1 reference

12 December 2020

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists

1 reference

12 December 2020

Pathophysiology of itching

1 reference

12 December 2020

Naltrexone and hepatotoxicity

1 reference

12 December 2020

Failure of rifampin to relieve pruritus in chronic liver disease

1 reference

12 December 2020

The incidence of pruritus after epidural morphine.

1 reference

12 December 2020

Ondansetron for pruritus due to cholestasis

1 reference

12 December 2020

Paroxysmal itching in multiple sclerosis

1 reference

12 December 2020

Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver

1 reference

12 December 2020

Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis.

1 reference

12 December 2020

Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.

1 reference

12 December 2020

Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease.

1 reference

12 December 2020

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial

1 reference

12 December 2020

The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers

1 reference

12 December 2020

Itching as a manifestation of noncutaneous disease.

1 reference

12 December 2020

Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial

1 reference

12 December 2020

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

12 December 2020

Cholestasis in the male rat is associated with naloxone-reversible antinociception

1 reference

12 December 2020

Natural history of pruritus in primary biliary cirrhosis

1 reference

12 December 2020

Peptide transport systems for opiates across the blood-brain barrier

1 reference

12 December 2020

Superficial dorsal horn neurons identified by intracutaneous histamine: chemonociceptive responses and modulation by morphine

1 reference

12 December 2020

Application of piezo film technology for the quantitative assessment of pruritus

1 reference

12 December 2020

Specific C-receptors for itch in human skin.

1 reference

12 December 2020

Further studies of scratching during sleep

1 reference

12 December 2020

Opioid peptides and primary biliary cirrhosis

1 reference

12 December 2020

Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus.

1 reference

12 December 2020

The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids

1 reference

12 December 2020

Intrahepatic cholestasis of pregnancy: review of the literature

1 reference

12 December 2020

Effects of central administration of opioids on facial scratching in monkeys

1 reference

12 December 2020

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study

1 reference

12 December 2020

Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch

1 reference

12 December 2020

Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin.

1 reference

12 December 2020

Scratching during sleep

1 reference

12 December 2020

Improved device for measuring scratching activity in patients with pruritus

1 reference

12 December 2020

Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus

1 reference

12 December 2020

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

12 December 2020

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

1 reference

12 December 2020

Role of plasmapheresis in primary biliary cirrhosis

1 reference

12 December 2020

Unilateral pruritus after a stroke

1 reference

12 December 2020

Pruritus as a presenting symptom of chronic hepatitis C

1 reference

12 December 2020

Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

1 reference

12 December 2020

Testosterone therapy for the pruritus of obstructive jaundice

1 reference

12 December 2020

Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Serotonin and nociception

1 reference

12 December 2020

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

12 December 2020

10.1007/S11894-004-0020-7

Identifiers

DOI

1 reference

9 August 2017

1 reference